[Various characteristics of the thrombohemorrhagic syndrome in a generalized form of meningococcal infection complicated by toxic-infectious shock]. 1986

A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev

Blood coagulation was studied in 19 patients with generalized meningococcal infection complicated by toxico-infectious shock (TIS). The outcomes were fatal in 42% of cases. Blood coagulation studies were done on days 1, 2, 3, 5-7 and 19-21 of treatment. Blood coagulability was found to be reduced drastically at the peak of disease: platelet aggregability was depressed substantially, and platelet secretory function showed profound disorders. The recovery of both plasma and platelet parameters of blood coagulation was rather slow. The magnitude of disorders may have a predictive value for the prognosis of the disease.

UI MeSH Term Description Entries
D008297 Male Males
D008585 Meningitis, Meningococcal A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) Meningitis, Neisseria,Neisseria Meningitis,Meningitis, Meningococcal, Serogroup A,Meningitis, Meningococcal, Serogroup B,Meningitis, Meningococcal, Serogroup C,Meningitis, Meningococcal, Serogroup W-135,Meningitis, Meningococcal, Serogroup W135,Meningitis, Meningococcal, Serogroup Y,Meningitis, Meningococcic,Meningococcal Meningitis, Serogroup A,Meningococcal Meningitis, Serogroup B,Meningococcal Meningitis, Serogroup C,Meningococcal Meningitis, Serogroup W-135,Meningococcal Meningitis, Serogroup W135,Meningococcal Meningitis, Serogroup Y,Serogroup A Meningococcal Meningitis,Serogroup B Meningococcal Meningitis,Serogroup C Meningococcal Meningitis,Serogroup W-135, Meningococcal Meningitis,Serogroup W135, Meningococcal Meningitis,Serogroup Y, Meningococcal Meningitis,Meningococcal Meningitis,Meningococcal Meningitis, Serogroup W 135,Neisseria Meningitides,Serogroup W 135, Meningococcal Meningitis
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
January 1987, Pediatriia,
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
February 1975, Klinicheskaia meditsina,
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
January 1993, Arkhiv patologii,
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
January 1989, Sovetskaia meditsina,
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
February 1989, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
November 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
October 1986, Journal of the Royal College of Surgeons of Edinburgh,
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
February 1982, Vrachebnoe delo,
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
July 1981, Problemy gematologii i perelivaniia krovi,
A M Poliakova, and L I Buriakovskaia, and O S Astrina, and Kh D Lomazova, and V V Maleev
April 1983, Postgraduate medical journal,
Copied contents to your clipboard!